These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1643649)

  • 21. Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.
    Blommaert FA; Michael C; Terheggen PM; Muggia FM; Kortes V; Schornagel JH; Hart AA; den Engelse L
    Cancer Res; 1993 Dec; 53(23):5669-75. PubMed ID: 8242622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas.
    Kawahara M; Takahashi Y; Takazawa K; Tsuchiya H; Tomita K; Yokogawa K; Miyamoto K
    Anticancer Res; 2008; 28(3A):1681-5. PubMed ID: 18630526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.
    Siwińska A; Opolski A; Chrobak A; Wietrzyk J; Wojdat E; Kutner A; Szelejewski W; Radzikowski C
    Anticancer Res; 2001; 21(3B):1925-9. PubMed ID: 11497279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline stimulates drug-induced apoptosis in leukemic cells.
    Rauko P; Sedlák J; Duraj J; Szekeres MF; Novotný L
    Neoplasma; 1998; 45(5):296-300. PubMed ID: 9921918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etoposide enhances the antitumor effects of cisplatin in gastric cancer cells.
    Hotta T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tsunoda T; Noguchi K; Mizobata S; Arii K; Terasawa H
    Anticancer Res; 1997; 17(2A):885-9. PubMed ID: 9137422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
    Kishi S; Goto N; Nakamura T; Ueda T
    Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
    Scheving LE; Burns ER; Halberg F; Pauly JE
    Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating response to antineoplastic drug combinations in tissue culture models.
    Reynolds CP; Maurer BJ
    Methods Mol Med; 2005; 110():173-83. PubMed ID: 15901935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of enhancement of cisplatin activity by high dose cytarabine in advanced gastric and colorectal (G3/G4) cancer.
    Popov I; Jelić S; Radulović S; Tomasević Z
    Neoplasma; 1996; 43(4):221-4. PubMed ID: 8931744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concepts of synergism and antagonism.
    Merlin JL
    Anticancer Res; 1994; 14(6A):2315-9. PubMed ID: 7825965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
    Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
    BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
    Berek JS; Schink JC; Knox RM
    Obstet Gynecol; 1989 Oct; 74(4):663-6. PubMed ID: 2797645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.
    Ghamande S; Hylander BL; Oflazoglu E; Lele S; Fanslow W; Repasky EA
    Cancer Res; 2001 Oct; 61(20):7556-62. PubMed ID: 11606394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
    [No Abstract]   [Full Text] [Related]  

  • 40. Rational approach to the clinical protocol design for drug combinations: a review.
    Chang TT; Chou TC
    Acta Paediatr Taiwan; 2000; 41(6):294-302. PubMed ID: 11198934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.